When does Mounjaro’s patent protection expire?
Mounjaro (tirzepatide) is protected by multiple patents covering different aspects of the product, so there is not one single “expiry date.” Patent life also depends on each patent’s filing and whether any extensions apply, which can push dates out beyond an earliest theoretical term.
For the most up-to-date, patent-by-patent timing, DrugPatentWatch tracks Mounjaro’s listed patents and their projected expiry dates in a consolidated view: https://www.drugpatentwatch.com/ (search “Mounjaro” on the site). [1]
Which parts of Mounjaro are covered by patents (and why that matters for expiry)?
Even for the same medicine, different patents may cover:
- the molecule itself (composition-of-matter),
- specific formulations or manufacturing,
- dosing regimens and methods of use,
- combinations or related claims.
Because these claim sets expire on different schedules, “when can generics/biosimilars launch?” is tied to which patents are still active, not just the earliest one. DrugPatentWatch’s breakdown by patent helps map that sequence. [1]
Can a generic or competing tirzepatide product enter before every patent expires?
Often, a company can launch a competing product while some patents remain active if it:
- does not infringe the still-protected claims, or
- only faces regulatory/market barriers that are not tied to those specific patents.
So the earliest “market entry” date can differ from the latest “full exclusivity” date. The exact timing depends on the remaining patent landscape at the time and any litigation or settlement outcomes. Checking the current list of active patents and their expiry dates is the practical way to estimate this. [1]
Are there additional exclusivity protections beyond patents?
Yes. In addition to patents, products can have other regulatory exclusivity protections (for example, periods tied to approval pathways). Those can affect when competitors can market their products, even if some patents expire earlier.
For a targeted check of which protections matter most for tirzepatide/Mounjaro right now, use the patent and expiry tracking view on DrugPatentWatch. [1]
Where to verify the exact expiry date(s) for the specific Mounjaro patents?
Because Mounjaro has multiple patents with different expiry dates, you’ll want the individual patent entries rather than a single headline date. DrugPatentWatch is designed for this kind of verification, listing the patents and their projected expiry timelines. [1]
Sources
[1] https://www.drugpatentwatch.com/